Design, synthesis, and evaluation of carbamate-substituted analogues of (+)-discodermolide

Organic Letters

Volumn 7, Issue 2, 2005, Pages 311-314

  Smith III, Amos B ^a   Freeze, B Scott ^a   LaMarche, Matthew J ^a   Hirose, Tomoyasu ^a   Brouard, Ignacio ^a   Rucker, Paul V ^a   Xian, Ming ^a   Sundermann, Kurt F ^b   Shaw, Simon J ^b   Burlingame, Mark A ^b   Horwitz, Susan Band ^c   Myles, David C ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b KOSAN BIOSCIENCES INC   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 ANHYDRODISCODERMOLIDE; CARBAMIC ACID DERIVATIVE; DISCODERMOLIDE; DISCODERMOLIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DESIGN; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION;

EID: 13444291392     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol047686a     Document Type: Article

References (38)

1. Gunasekera, S. P.; Gunasekera, M.; Longley, R. E.; Schulte, G. K. J. Org. Chem. 1990, 55, 4912-4915. Correction: J. Org. Chem. 1991, 56, 1346.
2. Gunasekera, S. P.; Gunasekera, M.; Longley, R. E.; Schulte, G. K. J. Org. Chem. 1990, 55, 4912-4915. Correction: J. Org. Chem. 1991, 56, 1346.
3. (a) ter Haar, E.; Kowalski, R. J.; Hamel, E.; Lin, C. M.; Longley, R. E.; Gunasekera, S. P.; Rosenkranz, H. S.; Day, B. W. Biochemistry 1996, 35, 243-250.
4. (b) Hung, D. T.; Chen, J.; Schreiber, S. L. Chem. Biol. 1996, 3, 287-293.
5. Kowalski, R. J.; Giannakakou, P.; Gunasekera, S. P.; Longley, R. E.; Day, B. W.; Hamel, E. Mol. Pharm. 1997, 52, 613-622.
6. Martello, L. A.; McDiad, H. M.; Regl, D. L.; Yang, C. H.; Meng, D.; Pettus, T. R.; Kaufman, M. D.; Arimoto, H.; Danishefsky, S. J.; Smith, A. B., III.; Horwitz, S. B. Clin. Cancer Res. 2000, 6, 1978-1987.
7. (a) Nerenberg, J. B.; Hung, D. T.; Somers, P. K.; Schreiber, S. L. J. Am. Chem. Soc. 1993, 115, 12621-12622.
8. (b) Smith, A. B., III; Qiu, Y.; Jones, D. R.; Kobayashi, K. J. Am. Chem. Soc. 1995, 117, 12011-12012.
9. (c) Harried, S. S.; Yang, G.; Strawn, M. A.; Myles, D. C. J. Org. Chem. 1997, 62, 6098-6099.
10. (d) Marshall, J. A.; Johns, B. A. J. Org. Chem. 1998, 63, 7885-7892.
11. (e) Smith, A. B., III; Kaufman, M. D.; Beauchamp, T. J.; LaMarche, M. J.; Arimoto, H. Org. Lett. 1999, 1, 1823-1826.
12. (f) Halstead, D. P. Ph.D. Thesis, Harvard University, Cambridge, MA, 1999.
13. (g) Paterson, J.; Florence, G. J.; Gerlach, K.; Scott, J. Angew. Chem., Int. Ed. 2000, 39, 377-380.
14. (h) Smith, A. B., III; Beauchamp, T. J.; LaMarche, M. J.; Kaufman, M. D.; Qiu, Y.; Arimoto, H.; Jones, D. R.; Kobayashi, K. J. Am. Chem. Soc. 2000, 122, 8654-8664.
15. (i) Paterson, I.; Florence, G. J.; Gerlach, K.; Scott, J. P.; Sereinig, N. J. Am. Chem. Soc. 2001, 123, 9535-9544.
16. (j) Harried, S. S.; Lee, C. P.; Yang, G.; Lee, T. I. H.; Myles, D. C. J. Org. Chem. 2003, 68, 6646-6660.
17. (k) Paterson, I.; Delgado, O.; Florence, G. J.; Lyothier, I.; Scott, J. P.; Sereinig, N. Org. Lett. 2003, 5, 35-38.
18. (l) Smith, A. B., III; Freeze, B. S.; Brouard, I.; Hirose, T. Org. Lett. 2003, 5, 4405-4408.
19. (m) Mickel, S. J.; Sedelmeier, G. H.; Niederer, D.; Daeffler, R.; Osmani, A.; Schreiner, K.; Seeger-Weibel, M.; Berod, B.; Schaer, K.; Gamboni, R.; Chen, S.; Chen, W.; Jagoe, C. T.; Kinder, F. R., Jr.; Loo, M.; Prasad, K.; Repic, O.; Shieh, W.-C.; Wang, R.-M.; Waykole, L.; Xu, D. D.; Xue, S. Org. Proc. Res. Dev. 2004, 8, 92-130 and references therein.
20. (n) Paterson, I.; Lyothier, I. Org. Lett. 2004, 6, 4933-4936.
21. (a) Hung, D. T.; Nerenberg, J. B.; Schreiber, S. L. Chem. Biol. 1994, 1, 67-71.
22. (b) Hung, D. T.; Nerenberg, J. B.; Schreiber, S. L. J. Am. Chem. Soc. 1996, 118, 11054-11080.
23. (c) Paterson, I.; Florence, G. J. Tetrahedron Lett. 2000, 41, 6935-6939.
24. (d) Gunasekera, S. P.; Longley, R. E.; Isbrucker, R. A. J. Nat. Prod. 2001, 64, 171-174.
25. (e) Isbrucker, R. A.; Gunasekera, S. P.; Longley, R. E. Cancer Chemother. Pharmacol. 2001, 48, 29-36.
26. (f) Martello, L. A.; LaMarche, M. J.; He, L.; Beauchamp, T. J.; Smith, A. B., III; Horwitz, S. B. Chem. Biol. 2001, 8, 843-855. As they were not included in the original paper, full experimental details for the compounds reported therein are provided in the Supporting Information of this work.
27. (g) Curran, D. P.; Furukawa, T. Org. Lett. 2002, 4, 2233-2235.
28. (h) Gunasekera, S. P.; Longley, R. E.; Isbrucker, R. A. J. Nat. Prod. 2002, 65, 1830-1837.
29. (i) Gunasekera, S. P.; Paul, G. K.; Longley, R. E.; Isbrucker, R. A.; Pomponi, S. A. J. Nat. Prod. 2002, 6, 1643-1648.
30. (j) Minguez, J. M.; Giuliano, K. A.; Balachandran, R.; Madiraju, C.; Curran, D. P.; Day, B. W. Mol. Cancer Ther. 2002, 1, 1305-1313.
31. (k) Shin, Y.; Choy, N.; Balachandran, R.; Madiraju, C.; Day, B. W.; Curran, D. P. Org. Lett. 2002, 4, 4443-4446.
32. (l) Choy, N.; Shin, Y.; Nguyen, P. Q.; Curran, D. P.; Balachandran, R.; Madiraju, C.; Day, B. W. J. Med. Chem. 2003, 46, 2846-2864.
33. (m) Minguez, J. M.; Kim, S.-Y.; Giuliano, K. A.; Balachandran, R.; Madiraju, C.; Day, B. W.; Curran, D. P. Bioorg. Med. Chem. 2003, 11, 3335-3357.
34. (n) Paterson, I.; Delgado, O. Tetrahedron Lett. 2003, 44, 8877-8882.
35. (o) Burlingame, M. A.; Shaw, S. J.; Sundermann, K. F.; Zhang, D.; Petryka, J.; Mendoza, E.; Liu, F.; Myles, D. C.; LaMarche, M. J.; Hirose, T.; Freeze, B. S.; Smith, A. B., III. Bioorg. Med. Chem. Lett. 2004, 14, 2335-2338.
36. (p) Gunasekera, S. P.; Mickel, S. J.; Daeffler, R.; Niederer, D.; Wright, A. E.; Linley, P.; Pitts, T. J. Nat. Prod. 2004, 67, 749-756.
37. For comparison, Gunasekera and co-workers recently reported the isolation of the natural product 19-descarbamoyldiscodermolide, which exhibits cytotoxicity 4-5-fold lower than that of (+)-discodermolide in the P388 and A549 cell lines. Gunasekera, S. P.; Paul, G. K.; Longley, R. E.; Isbrucker, R. A.; Pomponi, S. A. J. Nat. Prod. 2002, 65, 1643-1648.
38. Keck, G. E.; Krishnamurthy, D. Org. Synth. 1998, 75, 12-18.